Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Salestools Logo

Salestools

The #1 AI Agent for Sales teams and Go To Market teams. Sell more, faster, with less effort.

Product

  • AI Sales Agents
  • Intent Data
  • Technology Data
  • Visitor Tracking
  • Co-Pilot
  • Social Selling

Solutions

  • Customer Service
  • E-commerce
  • SaaS
  • Enterprise
  • Small Business

Resources

  • The Report
  • Documentation
  • API Reference
  • Help Center
  • Blog
  • Case Studies
  • Webinars

Company

  • About
  • Careers
  • Press
  • Contact
  • Partners

Our locations

  • New York, HQ
  • Bucharest, AI Research Lab
  • Zug, Switzerland

Β© 2026 Salestools. All rights reserved.

Data Terms & SecurityPrivacy PolicyTerms of ServiceAcceptable Use
All systems operational
Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Back to Reports
Fundraising

Sublime Security

Sublime Security Raises $150M in Series C

San Francisco, CAOctober 29, 20252 min read
Employees
150+

Sublime Security Raises $150M in Series C


Sublime Security has successfully raised $150M in a Series C at a $1B valuation led by Georgian, Accel, Sapphire Ventures.


Company Overview


Sublime Security is a Cybersecurity company headquartered in San Francisco, CA, founded in 2020 with 150+ employees.


Email security platform detecting and preventing advanced phishing and business email compromise


Fundraising Details


  • Amount Raised: $150M
  • Round Type: Series C
  • Valuation: $1B
  • Date: 2025-10-29
  • Investors: Georgian, Accel, Sapphire Ventures

About Sublime Security


Email security platform detecting and preventing advanced phishing and business email compromise The company is positioned in the Cybersecurity sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: San Francisco, CA
  • Founded: 2020
  • Team Size: 150+
  • Industry: Cybersecurity

What This Means


This funding round demonstrates strong investor confidence in Sublime Security's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Cybersecurity sector continues to attract significant investment as companies innovate to meet evolving market demands. Sublime Security's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $1B valuation marks an important milestone for Sublime Security, positioning the company among notable players in the Cybersecurity industry.


Looking Ahead


With this new capital, Sublime Security is well-positioned to execute on its growth strategy and continue building innovative solutions in the Cybersecurity space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-10-29. For more information about Sublime Security, visit their headquarters at San Francisco, CA.

Company Info

Headquarters
San Francisco, CA
Founded
2020
Team Size
150+

Topics

Fundraising(2912)Cybersecurity(455)Series C(300)Sublime Security

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min readβ€’$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min readβ€’$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min readβ€’$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free